首页|期刊导航|中医药信息|补肺汤加减配合电针对稳定期慢性阻塞性肺疾病肺脾气虚证运动耐力及血气分析指标的影响

补肺汤加减配合电针对稳定期慢性阻塞性肺疾病肺脾气虚证运动耐力及血气分析指标的影响OA

The Effects of Modified Bufei Decoction Combined with Electroacupuncture on Exercise Tolerance and Blood Gas Analysis Indicators for Chronic Obstructive Pulmonary Disease in Stable Period with Lung-Spleen Qi Deficiency Pattern

中文摘要英文摘要

目的 探讨补肺汤加减配合电针治疗对稳定期慢性阻塞性肺疾病(COPD)肺脾气虚证患者运动耐力及血气分析等相关指标的影响.方法 选取符合纳入标准的稳定期COPD肺脾气虚证患者,依据随机数字表随机分为对照组和研究组,每组各42例.对照组给予常规西医治疗,研究组在常规西医治疗基础上给予补肺汤加减联合电针治疗,治疗周期3个月.记录两组患者咳嗽、喘息缓解时间,以及肺部啰音消失时间;采用呼吸困难指数(MMRC)量表、Barthel指数量表和六分钟步行试验(6MWT)评估患者呼吸和运动能力;使用血气分析仪测定血氧饱和度(SaO2)、动脉氧分压(PaO2)及动脉二氧化碳分压(PaCO2);使用肺功能仪测定肺功能[第1秒用力呼气容积(FEV1)、用力肺活量(FVC)、最大呼气峰流速值(PEF)];酶联免疫吸附法测定C反应蛋白(CRP)、肿瘤坏死因子-α(TNF-α)及白细胞介素-6(IL-6);对咳喘无力、气短懒言、恶风自汗中医症状进行评分.随访1年,记录急性发作次数、再入院率,同时采用COPD评估测试量表(CAT)评估生活质量.结果 研究组治疗总有效率92.86%(39/42),显著优于对照组73.81%(31/42);研究组咳嗽、喘息缓解时间及肺部啰音消失时间均显著短于对照组(P<0.05).与治疗前比较,两组MMRC评分、CRP、TNF-α、IL-6、PaCO₂水平和咳喘无力、气短懒言、恶风自汗中医症状评分均显著降低(P<0.05),6MWT、Barthel指数、SaO₂、PaO₂水平,以及FVC、FEV₁、PEF水平均显著增加(P<0.05),且研究组上述指标改善情况明显优于对照组(P<0.05).治疗结束后随访1年,研究组急性发作次数、再入院率及CAT评分均显著低于对照组(P<0.05).结论 补肺汤加减联合电针协同治疗,能显著减轻稳定期COPD肺脾气虚证患者咳喘等临床表现,有效促进呼吸与肺功能恢复,提升运动耐力、优化生活品质、降低急性加重风险.

Objective To investigate the effects of modified Bufei Decoction combined with electroacupuncture on exercise tolerance and blood gas analysis-related indicators in patients of chronic obstructive pulmonary disease(COPD)in stable period with lung-spleen qi deficiency pattern.Methods Patients of COPD in stable period with lung-spleen qi deficiency pattern who met the inclusion criteria were randomly divided into a control group and a study group using a random number table,with 42 cases in each group.The control group received conventional Western medical treatment,while the study group received modified Bufei Decoction combined with electroacupuncture in addition to the conventional Western medical treatment.The treatment lasted for 3 months for both groups.The time to relief of cough and wheezing,as well as the time to disappearance of lung rales,were recorded for both groups.Respiratory and exercise capacity were assessed using the Modified Medical Research Council(MMRC)Dyspnea Scale,the Barthel Index,and the 6-minute walk test(6MWT).Arterial oxygen saturation(SaO2),arterial partial pressure of oxygen(PaO2),and arterial partial pressure of carbon dioxide(PaCO2)were measured using a blood gas analyzer.Pulmonary function parameters[forced expiratory volume in one second(FEV1),forced vital capacity(FVC),and peak expiratory flow(PEF)]were measured using a spirometer.Serum levels of C-reactive protein(CRP),tumor necrosis factor-α(TNF-α),and interleukin-6(IL-6)were measured using the enzyme-linked immunosorbent assay.TCM symptoms,including cough and asthma with weakness,shortness of breath and reluctance to speak,and aversion to wind and spontaneous sweating,were scored.Patients were followed for one year,the number of acute exacerbations and hospital readmissions rates were recorded.Quality of life was also assessed using the COPD Assessment Test(CAT).Results The total effective rate in the study group was 92.86%(39/42),which was significantly higher than the rate of 73.81%(31/42)in the control group.The time to relief of cough and wheezing,as well as the time to disappearance of lung rales in the study group were significantly shorter than those of the control group(P<0.05);Both groups showed significant reductions in MMRC scores,CRP,TNF-α,IL-6,and PaCO₂ levels,as well as TCM symptom scores of cough and asthma with weakness,shortness of breath and reluctance to speak,and aversion to wind and spontaneous sweating,compared to the baseline(P<0.05).The 6MWT,Barthel index,SaO2 and PaO2 levels,as well as the FVC,FEV1,and PEF levels,were significantly increased(P<0.05).Furthermore,the improvement in these parameters was superior in the study group compared to the control group(P<0.05).During the one-year follow-up after treatment,the study group showed significantly lower frequencies of acute exacerbations,lower readmission rates,and lower CAT scores than the control group(P<0.05).Conclusion Modified Bufei Decoction combined with electroacupuncture can not only significantly alleviate clinical symptoms such as cough and asthma,effectively promote respiratory and lung function recovery,but also improve exercise tolerance,optimize quality of life,and reduce the risk of acute exacerbation for patients of COPD in stable period with lung-spleen qi deficiency pattern.

刘开心;王明庆;常福生;尉飞

新乡市中医院,河南 新乡 453003新乡市中医院,河南 新乡 453003新乡市中医院,河南 新乡 453003河南省中医院(河南中医药大学第二附属医院),河南 郑州 450002

慢性阻塞性肺疾病稳定期补肺汤电针肺功能运动耐力血气分析

Chronic obstructive pulmonary diseaseStable periodBufei DecoctionElectroacupuncturePulmonary functionExercise toleranceBlood gas analysis

《中医药信息》 2026 (6)

58-63,6

河南省中医药科学研究专项课题(2023ZY2070)

10.19656/j.cnki.1002-2406.20260609

评论